List of Organon's Acquisitions
Recent acquisitions by Organon
Organon's most recent acquisition - Dermavant is a Developer of small molecule based therapeutics for the treatment of inflammatory skin diseases, founded in 2016 and located in Phoenix. Organon acquired it in October 2024 for a price of $*****.
Here is the list of all acquisitions by Organon sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Sep 18, 2024 | khcr | rq{x | 89 | 210 | |
Nov 11, 2021 | xzpe | wflc | 10 | 590 | |
Mar 30, 2021 | {c{h | lobo | 51 | 315 |
View the full list of acquisitions
Sign Up for FreeNews related to Organon's acquisitions
Media has covered Organon for a total of 45 events in the last 1 year, 17 of them have been about acquisition activity.
•
Sun Pharma inches closer to biggest-ever buyout as Organon shareholders approve mergerMoneycontrol•Jul 24, 2026•Sun Pharma, Organon, Immuneel
•
India's M&A values hit four-year high in Q2 due to cross-border acquisitions, despite lower deal volume: ReportLokmat•Jul 06, 2026•Sun Pharma, Organon, Apotex, Sandoz and 2 others
•
SBI to fund Sun Pharma's $12bn Organon acquisition with $1bnLivemint•Jun 09, 2026•Organon, Sun Pharma
•
Buy Sun Pharma Ltd for the Target Rs. 2,025 by Motilal Oswal Financial Services LtdInvestment Guru India•Jun 02, 2026•Sun Pharma, Organon
•
•
Sun Pharma Explores Debt Swap for Organon Acquisition FinancingMedical Dialogues•May 06, 2026•Organon, Sun Pharma
•
Sun Pharma's M&A Deal Signals Fading Allure of US Generics BusinessLivemint•Apr 28, 2026•Organon, Sun Pharma
•
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?PR Newswire•Apr 27, 2026•Organon, RE/MAX, Real, XOMA Corporation and 10 others
•
Sun Pharma to acquire US-listed Organon in $12 billion dealMoneycontrol•Apr 27, 2026•Organon, Sun Pharma, Ademi, Merck
•
Sun Pharma slips nearly 4% after $12 billion Organon deal enters final stageMoneycontrol•Apr 10, 2026•Organon, Sun Pharma, EQT, Gruenenthal Group